Status:
COMPLETED
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM)
Lead Sponsor:
Endocrine Research Society
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
Management of diabetes is an evolving challenge to health care professionals. The fluctuations of glucose levels over the lifetime of patients with diabetes can lead to complications such as nephropat...
Detailed Description
Purpose: To determine whether use of an Internet-based glucose monitoring system improves A1C levels in patients with type 2 diabetes mellitus. Hypothesis:We propose that the standardized encounters ...
Eligibility Criteria
Inclusion
- Type 2 diabetes patients treated with insulin
- A1C 7-11%
- \>25 years of age
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be randomized
- Trained in self blood glucose monitoring
- Internet Access
Exclusion
- Patients who do not meet the inclusion criteria or are not willing to participate will not be included in the study.
- In addition patients with the potential to become pregnant or patients using medications known to influence control of diabetes (eg steroids systemic or inhaled) are excluded from the study.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00814190
Start Date
January 1 2009
End Date
November 1 2009
Last Update
January 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6